Skip to main content
V

Victus88

The startup provides diagnostic testing services that utilize advanced platforms and specialty tests to enhance precision medicine. It addresses the issues of unreliable testing methods, excessive turnaround times, and high costs, enabling healthcare providers to deliver accurate and timely patient care.

Collinsville, United StatesFounded 202150+ followers
Updated 3 months ago

Funding

$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current diagnostic testing methods can suffer from unreliability, long turnaround times, and high costs, hindering the delivery of timely and accurate patient care. This can lead to delays in diagnosis and treatment, potentially impacting patient outcomes.

Solution

Biovision Diagnostics is a CLIA-registered medical laboratory that provides a range of diagnostic and specialty testing services designed to enhance precision medicine. The company focuses on delivering accurate and timely results through advanced platforms and a commitment to compliance. By offering superior customer service, proprietary test quality, and competitive pricing, Biovision Diagnostics aims to be a premier specialty laboratory for institutional clients and healthcare providers. Their testing portfolio includes options for COVID-19, gut health, sexually transmitted infections, respiratory pathogens, workplace drug testing, pharmacogenetics, and medication monitoring.

Target Audience

Biovision Diagnostics primarily serves institutional clients and healthcare providers seeking reliable and precise diagnostic testing services to improve patient care. The Victus88 test is available directly to consumers.

Features

  • Comprehensive at-home food sensitivity test (Victus88) that measures immune reactions to 88 food antigens using four biomarkers.
  • Proprietary algorithm to calculate the severity level for each food sensitivity.
  • COVID-19 testing services.
  • Testing services for Sexually Transmitted Infections (STI).
  • Respiratory Pathogen Panels (RPP).
  • Workplace drug testing services.
  • Pharmacogenetics (PGx) testing.
  • Medication monitoring services.
This profile is AI-generated and may contain inaccuracies.